ANAB vs GPCR: stock comparison and AI forecast
Anaptysbio, Inc (ANAB) and Structure Therapeutics Inc. (GPCR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ANAB Anaptysbio, Inc
- Market Cap
- $1.36B
- P/E Ratio
- 11.9x
- Size
- small-cap
- AI Forecast
GPCR Structure Therapeutics Inc.
- Price
- $19.08 -51.3% · 6M
- Market Cap
- $1.40B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ANAB and GPCR have similar market capitalizations ($1.36B and $1.40B).
- ANAB carries 28.95 times debt per unit of equity, against 0.05 times for GPCR.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ANAB | GPCR |
|---|---|---|
| Market Cap | $1.36B | $1.40B |
| P/E Ratio | 11.93x | – |
| P/B Ratio | 128.73x | 1.03x |
| EPS | $3.82 | $-0.66 |
| Book Value/Share | $0.35 | $18.52 |
| Revenue/Share | $8.80 | – |
| FCF/Share | – | $-3.07 |
Profitability & Margins
| Metric | ANAB | GPCR |
|---|---|---|
| ROIC | 35.3% | -19.0% |
| Operating Margin | 33.6% | – |
| EBT Margin | 2.3% | – |
| Tax Rate | -2639.1% | -0.3% |
Financial Health
| Metric | ANAB | GPCR |
|---|---|---|
| Current Ratio | 5.61x | 20.75x |
| D/E Ratio | 28.95x | 0.05x |
| Financial Leverage | 29.95x | 1.05x |
| Interest Coverage | 0.8x | – |
| Working Capital | $163M | $1.31B |
Cash Flow
| Metric | ANAB | GPCR |
|---|---|---|
| Operating Cash Flow | -$8M | -$220M |
| Free Cash Flow | – | -$224M |
| Capital Spending | – | -$4M |
Operational Efficiency
| Metric | ANAB | GPCR |
|---|---|---|
| Asset Turnover | 0.83x | – |
| Receivables Turnover | 10.3x | – |
| Fixed Assets Turnover | 2580.1x | – |
| Days Sales Outstanding | 36 days | – |
Income Statement
| Metric | ANAB | GPCR |
|---|---|---|
| Total Revenue | $263M | – |
| Operating Income | $99M | -$258M |
| R&D Expense | $129M | $294M |
Dividend & Shareholder Information
| Metric | ANAB | GPCR |
|---|---|---|
| Shares Outstanding | 30M | 73M |
ANAB vs GPCR: stock comparison and AI forecast
Which is bigger, ANAB or GPCR?
ANAB and GPCR have similar market capitalizations ($1.36B and $1.40B).
Which one does Intratio's AI model rank higher, ANAB or GPCR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.